Latest filing published 04 Jan 2022 for iTeos Therapeutics, Inc., €58k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Detlev Biniszkiewicz: trading record in brief
Detlev Biniszkiewicz, listed as board member, appears in our data through filings on iTeos Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 2 filings, all for trades on 3 January 2022.
The open-market record consists of 1 sale worth €160k, with no purchase. Besides market trades, the filings include 1 option exercise.
The newest entry dates from 4 January 2022: an open-market sale of €160k, in iTeos Therapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Detlev Biniszkiewicz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,500 shares@ US$19.00100.0% of flowCommon StockSEC:0001209191-22-001339:0
1 of 1 declaration
